I own it in my Roth also (3700 shares), but also have a small (1000 shares) in a regular brokerage account. I really like the company, but most importantly I love the price. If successful, the share price can easily go to $50+ in the next 24 months. America needs a non-addictive pain drug and there is a HUGE demand for it. We could be sitting on a gold mine here. I am very excited for everyone holding a long position in CARA. As long as the chart looks positive, I will be holding this stock.
Market Data 
Markets 
AI
